Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

The treatment combining laser and fetal fibroblasts effectively reduces scarring.

SMAs improve patient satisfaction and may be cost-effective for female hair loss.

A genetic marker linked to a type of hair loss was found in most patients studied.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

FGF21 can help reduce skin inflammation caused by C. acnes.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.

Women with Frontal Fibrosing Alopecia have more wrinkles near their ears than similar aged women without the condition.

Tofacitinib is an effective and safe treatment for alopecia areata.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Trichoscopy helps diagnose frontal fibrosing alopecia in Caucasians, but more research is needed.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Traumatic anserine folliculosis is a harmless skin condition in young males that needs correct diagnosis to avoid unnecessary treatments.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Genetic testing can help diagnose skin conditions but needs more research for full effectiveness.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.